This information sheet discusses hepatitis A virus (HAV). It explains how it is transmitted, its symptoms, and prevention, including getting the hepatitis A vaccination.

This information sheet discusses drug interactions, specifically drug interactions with medications for hepatitis C virus (HCV) infection, including interactions between drugs and herbal medications and drug-drug interactions. It also discusses food and drink interactions and overdosing.

This information sheet discusses the liver and its importance to the body. It describes how the liver acts as a filter for everything that an individual eats, drinks, or breathes in and how some things, such as alcohol, street drugs, and smoke, cause liver damage. It also explains that the hepatitis C virus (HCV) can cause scarring to the liver and over a long period of time can cause the liver to not function properly. The information sheet provides tips to keep the liver healthy.

This information sheet discusses the challenges to drug resistant gonorrhea, why we should care about it, which regions experience the most cases, and prevention efforts to prevent an epidemic.

This report outlines a collection of STD resources for health officials that may offer innovative solutions for reducing infectious diseases in a dynamic healthcare environment.

This report outlines opportunities for leadership engagement that promotes core public health, with case examples specific to STD prevention. The opportunities in this report fall under four areas: partnerships, payment, workforce, and surveillance.

This report discusses the role of states in addressing hepatitis. It talk about federally-funded programs, expanded health insurance coverage, transmission, surveillance, and funding levels.

This report takes literature review, interviews, and an in-person meeting to examine the current status of integration of services provided for STDs and how transitioning to a more integrated model can be successful.

This information sheet discusses expedited partner therapy in Texas, which is the practice of treating sex partners of heterosexual patients diagnosed with chlamydia or gonorrhea without an exam from a health care provider.

This information sheet discusses the burden and challenges of TB in women. It states that TB is the second leading cause of death from a single infectious agent worldwide.